| Literature DB >> 26891466 |
Tian Zhang1, Xinjing Wang1, Zhen Huo1, Yuan Shi1, Jiabin Jin1, Qian Zhan1, Hao Chen1, Xiaxing Deng1, Baiyong Shen1.
Abstract
BACKGROUND Postoperative pancreatic fistulas (POPFs) due to anastomotic leaks are always closely related to significant morbidity and mortality following pancreaticoduodenectomy (PD). A series of modified anastomotic methods have been proposed. The object of our study was to provide a novel anastomotic method for operations involving the Child technique, termed the "whole-layer tightly appressed anastomosis technique". MATERIAL AND METHODS An improved pancreatic whole-layer suture technique was used when we performed the duct-to-mucosa pancreaticojejunostomies; this method ensured the tight joining of the pancreatic stump and jejunum and decreased the pinholes in the pancreatic stump. This new method was used in 41 patients, and was compared with the traditional duct-to-mucosa anastomosis technique that was used in 50 patients as controls. RESULTS The POPF rate was much lower in the new method group than in the control group (6, 14.63% and 20, 40.00%, respectively, P=0.010). There were 5 grade A POPF patients and 1 grade B POPF patient in the study group. In the control group there were 12 grade A POPFs patients, 7 grade B POPFs patients, and 1 grade C POPF patient. The study group exhibited a lower morbidity rate (7, 17.07% vs. 16, 32.00%, P=0.022) and a reduced hospital stay (17.16 d vs. 22.92 d, P=0.001). CONCLUSIONS The whole-layer tightly appressed anastomosis technique presented in our study is a safer anastomotic method than the traditional duct-to-mucosa pancreaticojejunostomy technique. This new technique effectively reduced the incidence of POPF after PD and decreased the postoperative morbidity.Entities:
Mesh:
Year: 2016 PMID: 26891466 PMCID: PMC4762297 DOI: 10.12659/msm.896853
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Baseline demographic characteristics of the patients.
| Parameters | Study group | Control group | P Value |
|---|---|---|---|
| Total no. of patients | 41 | 50 | |
| Mean age (y) | 57.90±14.32 | 58.12±11.60 | 0.936 |
| Mean BMI (kg/m2) | 22.43±3.07 | 23.68±5.76 | 0.213 |
| No. male/female | 26/15 | 36/14 | 0.498 |
| Serum total bilirubin (μmol/L) | 89.74±98.91 | 96.74±100.58 | 0.740 |
| DM | 9 | 6 | 0.260 |
BMI – body mass index; DM – diabetes mellitus.
Unpaired t test;
chi-square test.
Figure 2Intraoperative photographs of the formation of the pancreaticojejunostomy anastomoses. (A) The enterotomies were made with electrocautery. The diameter of the O-ring was approximately 2–3 mm. (B) The suturing of the posterior row of inner layer of the anastomosis. The needle went through the whole layer of the pancreatic parenchyma. We utilized the interrupted suturing method. (C) The insertion of the stent tube. (D) The suturing of the anterior row of inner layer of the anastomosis. (E) Completing the suturing of inner layer.
Figure 1(A) First, we pushed the needle through the O-ring at full thickness in the jejunum. Next, we pushed the needle through the epithelium of the main pancreatic duct and then pulled the needle out from the pancreatic serosa to include the whole layer of the pancreatic parenchyma. (B) The treatments of the upper and lower sides of the pancreatic parenchyma. We first pushed the needle out from the middle of the pancreatic parenchyma and then inserted the needle in situ and pulled it out from the pancreatic serosa.
Intraoperative data and postoperative outcomes.
| Event | Study group | Control group | P value |
|---|---|---|---|
| Operating time (min) | 234.50±44.12 | 252.32±49.94 | 0.062 |
| Blood loss (ml) | 351.46±407.42 | 454.00±352.95 | 0.202 |
| Time of anastomosis (min) | 15.73±1.75 | 15.48±1.79 | 0.057 |
| Blood transfusion | 10 | 21 | 0.078 |
| Tumor size (cm) | 3.12±1.48 | 3.65±1.73 | 0.210 |
| Malignant/Benign | 33/8 | 46/4 | 0.128 |
| POPF | 6 | 20 | 0.010 |
| Grade A | 5 | 12 | |
| Grade B | 1 | 7 | |
| Grade C | 0 | 1 | |
| Grade B+C | 1 | 8 | 0.038 |
| Diameter of pancreatic duct ≤3 cm | 26 | 36 | 0.382 |
| Soft pancreas | 15 | 23 | 0.467 |
| Complication | 7 | 16 | 0.022 |
| Grade 1–2 | 6 | 15 | |
| Grade 3–5 | 1 | 1 | |
| Reoperation | 0 | 1 | 1.000 |
| Time of intake (d) | 5.11±1.93 | 7.20±4.11 | 0.005 |
| Time of drain-tube-off (d) | 11.55±9.41 | 17.83±7.67 | 0.008 |
| Postoperative stay (d) | 17.16±7.04 | 22.92±8.20 | 0.001 |
| No. of complications | 7 | 16 | |
| Time of intake | 6.29±2.14 | 9.50±4.94 | 0.116 |
| Time of drain-tube removal | 24.86±12.20 | 20.94±9.57 | 0.415 |
| Postoperative stay | 23.43±9.40 | 28.63±8.97 | 0.221 |
POPF – post-operative pancreatic fistula.
Unpaired t test;
chi-square test;
data for patients with postoperative complications.
Risks for POPF.
| Event | POPF (n=26) | Non-POPF (n=65) | P value |
|---|---|---|---|
| Age (y) | 58.35±11.25 | 57.89±13.47 | 0.880 |
| Sex (male/female) | 19/7 | 43/22 | 0.522 |
| BMI (kg/m2) | 23.64±3.17 | 22.91±5.27 | 0.513 |
| Preoperative serum total bilirubin (μmol/L) | 72.01±81.67 | 104.98±109.17 | 0.191 |
| Incidence of DM (cm) | 6/20 | 9/56 | 0.284 |
| Pancreatic texture (soft/hard) | 9/17 | 29/36 | 0.382 |
| Pathology (malignant/benign) | 25/1 | 54/11 | 0.168 |
| Pancreatic duct diameter ≤3 m | 20 | 42 | 0.255 |
| Blood loss (ml) | 437.92±399.54 | 396.92±411.37 | 0.835 |
| Intraoperative transfusion (%) | 13/13 | 18/47 | 0.043 |
| Operating time (min) | 285.00±59.92 | 275.38±77.91 | 0.573 |
BMI – body mass index; DM – diabetes mellitus.
Unpaired t test;
chi-square test.
Logistic regression of risk factors of PF after pancreaticoduodenectomy.
| Value | B | SE | Wals | P value | OR | 95%CI |
|---|---|---|---|---|---|---|
| Total PFs transfusion | 0.960 | 0.480 | 3.993 | 0.046 | 2.611 | 1.019–6.693 |
B – regression coefficient; PF – pancreatic fistula; Wals – χ2 value.
Postoperative complications in 91 patients.
| Postoperative complications | Study group | Control group |
|---|---|---|
| Ascites | 2 | 3 |
| Gastrointestinal hemorrhage | 1 | 1 |
| Delayed gastric emptying | 1 | 2 |
| Biliary fistula | 0 | 3 |
| Pulmonary infection | 0 | 1 |
| Wound infection | 1 | 2 |
| Urinary tract infection | 0 | 1 |
| Abdominal infection | 2 | 4 |